ALKBH7 and glioblastoma: Stable knockdown of ALKBH7 in glioblastoma cells resulted in smaller xenografts (p < 0.01), which implied that ALKBH7 depletion in glioblastoma cells effectively restored the sensitivity of TMZ in vivo (Figure 7A,B).